
Qiagen revenue 2012-2024
This statistic shows the development of the revenue of Dutch biotech company Qiagen from 2012 to 2024. In 2024, net sales of this company stood at 1.987 billion U.S. dollars. Qiagen N.V. is headquartered in the Netherlands and in Germany, and is operating in many countries around the world. The company specializes in sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research.